Current Neuropharmacology
Volume 19, 12 Issues, 2021
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Current Neuropharmacology, Volume 16 - Number 5
Biography Open Access
Editorial Open Access
Review Article
Microglia and Astrocytes in Alzheimer's Disease: Implications for Therapy
, 16(5): 508 - 518Marc Fakhoury*
DOI: 10.2174/1570159X15666170720095240
Microglia and Astrocytes in Alzheimer's Disease: Implications for Therapy
Review Article
Neuron-glia Interaction as a Possible Pathophysiological Mechanism of Bipolar Disorder
, 16(5): 519 - 532Jairo Vinicius Pinto, Ives Cavalcante Passos, Diego Librenza-Garcia, Grasiela Marcon, Maiko Abel Schneider, Joao Henrique Conte, Joao Pedro Abreu da Silva, Luiza Pereira Lima, Andre Quincozes-Santos, Marcia Kauer-Sant`Anna and Flavio Kapczinski*
DOI: 10.2174/1570159X15666170828170921
Neuron-glia Interaction as a Possible Pathophysiological Mechanism of Bipolar Disorder
Review Article
Imaging the Role of Inflammation in Mood and Anxiety-related Disorders
, 16(5): 533 - 558Jennifer C. Felger*
DOI: 10.2174/1570159X15666171123201142
Imaging the Role of Inflammation in Mood and Anxiety-related Disorders
Review Article
The Microbiota-Gut-Brain Axis in Neuropsychiatric Disorders: Pathophysiological Mechanisms and Novel Treatments
, 16(5): 559 - 573Yong-Ku Kim and Cheolmin Shin*
DOI: 10.2174/1570159X15666170915141036
The Microbiota-Gut-Brain Axis in Neuropsychiatric Disorders: Pathophysiological Mechanisms and Novel Treatments
Review Article
Neuroinflammation and the Immune-Kynurenine Pathway in Anxiety Disorders
, 16(5): 574 - 582Yong-Ku Kim and Sang Won Jeon*
DOI: 10.2174/1570159X15666170913110426
Neuroinflammation and the Immune-Kynurenine Pathway in Anxiety Disorders
Review Article
Protein-C Reactive as Biomarker Predictor of Schizophrenia Phases of Illness? A Systematic Review
, 16(5): 583 - 606Laura Orsolini, Fabiola Sarchione, Federica Vellante, Michele Fornaro, Ilaria Matarazzo , Giovanni Martinotti, Alessandro Valchera, Marco Di Nicola, Alessandro Carano, Massimo Di Giannantonio, Giampaolo Perna, Luigi Olivieri and Domenico De Berardis*
DOI: 10.2174/1570159X16666180119144538
Protein-C Reactive as Biomarker Predictor of Schizophrenia Phases of Illness? A Systematic Review
Editorial Open Access
Editorial; The Role of Ca2+-activated K+ Channels of Intermediate Conductance in Glioblastoma Malignancy
, 16(5): 607Luigi Catacuzzeno and Fabio Franciolini
DOI: 10.2174/1570159X1605180510154222
Review Article
Structure, Gating and Basic Functions of the Ca2+-activated K Channel of Intermediate Conductance
, 16(5): 608 - 617Luigi Sforna, Alfredo Megaro, Mauro Pessia, Fabio Franciolini* and Luigi Catacuzzeno*
DOI: 10.2174/1570159X15666170830122402
Structure, Gating and Basic Functions of the Ca2+-activated K Channel of Intermediate Conductance
Review Article
KCa3.1 Channel Modulators as Potential Therapeutic Compounds for Glioblastoma
, 16(5): 618 - 626Brandon M. Brown, Brandon Pressley and Heike Wulff*
DOI: 10.2174/1570159X15666170630164226
KCa3.1 Channel Modulators as Potential Therapeutic Compounds for Glioblastoma
Review Article
KCa3.1 Channels and Glioblastoma: In Vitro Studies
, 16(5): 627 - 635Lukas Klumpp, Efe C. Sezgin, Marco Skardelly, Franziska Eckert and Stephan M. Huber*
DOI: 10.2174/1570159X15666170808115821
KCa3.1 Channels and Glioblastoma: In Vitro Studies
Review Article
Functional Roles of the Ca2+-activated K+ Channel, KCa3.1, in Brain Tumors
, 16(5): 636 - 643Giuseppina D`Alessandro, Cristina Limatola* and Myriam Catalano
DOI: 10.2174/0929867324666170713103621
Functional Roles of the Ca2+-activated K+ Channel, KCa3.1, in Brain Tumors
Editor-in-Chief
F. Nicoletti
University Rome"da Sapienza"
Rome
(Italy)
University Rome"da Sapienza"
Rome
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Neuropharmacology was introduced in 2003 and Dr. Ferdinando Nicoletti is the New Editor-in-Chief of the journal, appointed in 2019.
Scopus CiteScore Metrics: 4.72
New eBook
 |
Neurobiology of Mood DisordersYou can view the contents of this eBook [here] or purchase it [here]. |
Advertisement
Webmaster Contact: info@benthamscience.net